HomeAdministrativeBilling & ReimbursementBlueCardHealth and WellnessMedicalNaviNet OpenPharmacyProductsQuality Management

MedicalOpioid Awareness

Outbreak of life-threatening coagulopathy associated with synthetic cannabinoids use 

December 14, 2018    

The Centers for Disease Control and Prevention (CDC) has provided information on a multistate outbreak of coagulopathy from exposure to synthetic cannabinoids products containing a vitamin K-epoxide cycle antagonist, brodifacoum. To learn more about this outbreak, and what you can do to help your patients who may be affected by it, please refer to the CDC’s alert.




Connect with us    Facebook     Twitter     Flickr     YouTube    Walk the Talk   Independence Pinterest   Independence Google+   Independence LinkedIn   Independence InstagramSite Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2019 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.